Recently, a consensual definition of sensitive skin has been given. Sensitive skin is defined by the occurrence of unpleasant sensations (stinging, burning, pain, pruritus, and tingling sensations) in response to stimuli that normally should not provoke such sensations. These unpleasant sensations cannot be explained by lesions attributable to any other skin disease. The skin can appear normal or be accompanied by erythema. Sensitive skin can affect all body locations, especially the face. The pathophysiology remains debated. There are conflicting hypotheses regarding the role of epidermal cells, nerve endings and blood vessels, as well as the role of inherited and environmental factors, the epidemiology of sensitive skin, the methods of investigation and the therapeutic consequences. All contributions on this Research Topic are welcomed, with the aim to provide a comprehensive review of current issues.
Topic editor, Dr. Misery, has declared potential conflicts of interest with Beiersdorf, Bioderma, Clarins, Expanscience, Johnson & Johnson, Nestlé Skin Health, Pierre Fabre, Roche-Posay, Solabia and Dr. Richers has declared a potential conflict of interest with Philips. All other topic editors declare no competing interests with regards to the Research Topic subject.
Recently, a consensual definition of sensitive skin has been given. Sensitive skin is defined by the occurrence of unpleasant sensations (stinging, burning, pain, pruritus, and tingling sensations) in response to stimuli that normally should not provoke such sensations. These unpleasant sensations cannot be explained by lesions attributable to any other skin disease. The skin can appear normal or be accompanied by erythema. Sensitive skin can affect all body locations, especially the face. The pathophysiology remains debated. There are conflicting hypotheses regarding the role of epidermal cells, nerve endings and blood vessels, as well as the role of inherited and environmental factors, the epidemiology of sensitive skin, the methods of investigation and the therapeutic consequences. All contributions on this Research Topic are welcomed, with the aim to provide a comprehensive review of current issues.
Topic editor, Dr. Misery, has declared potential conflicts of interest with Beiersdorf, Bioderma, Clarins, Expanscience, Johnson & Johnson, Nestlé Skin Health, Pierre Fabre, Roche-Posay, Solabia and Dr. Richers has declared a potential conflict of interest with Philips. All other topic editors declare no competing interests with regards to the Research Topic subject.
